Your browser doesn't support javascript.
loading
Development of an EORTC Item Bank for Computer-Adaptive Testing of Nausea and Vomiting.
Puskulluoglu, Miroslawa; Petersen, Morten Aa; Holzner, Bernhard; Kemmler, Georg; Velikova, Galina; Young, Teresa; Tomaszewska, Iwona; Groenvold, Mogens.
Affiliation
  • Puskulluoglu M; Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków Branch, Kraków, Poland. Electronic address: mira.puskulluoglu@gmail.com.
  • Petersen MA; Research Unit, Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
  • Holzner B; Department of Psychiatry, Psychotherapy and Psychosomatics, Innsbruck Medical University, Innsbruck, Austria.
  • Kemmler G; Department of Psychiatry, Psychotherapy and Psychosomatics, Innsbruck Medical University, Innsbruck, Austria.
  • Velikova G; Patient Reported Outcomes Group, St James's Institute of Oncology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, West Yorkshire, UK.
  • Young T; Mount Vernon Cancer Centre, East & North Herts NHS Trust, Northwood, Middx HA6 2RN United Kingdom.
  • Tomaszewska I; Department of Medical Education, Jagiellonian University Medical College, 16 sw. Lazarza St, 31-530, Kraków, Poland.
  • Groenvold M; Research Unit, Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen, Denmark; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Semin Oncol Nurs ; 38(6): 151341, 2022 12.
Article de En | MEDLINE | ID: mdl-36280540
ABSTRACT

OBJECTIVES:

Nausea and vomiting (NV) remain common cancer symptoms and frequent side effects of anticancer therapies despite available antiemetics. They can lead to treatment disruption and discontinuation. NV is an important patient reported outcome in oncology. This study aimed to build an item bank for computer-adaptive testing (CAT) based on NV questions in the European Organisation for Research for Treatment of Cancer, Quality of Life for Cancer Patients (EORTC QLQ-C30) questionnaire and complete the first three phases of development as described in the EORTC Quality of Life Group guidelines. DATA SOURCES The development followed a standard procedure. The three phases include conceptualization and literature search (phase 1); item classification, selection, formulation and rating, and expert evaluations (phase 2); and patient pretesting (phase 3). The literature search resulted in a preliminary list of 115 items. Following classification, formulation, and rating, 21 candidate items adhered to the QLQ-C30 format. Evaluation by experts (n = 11) from five countries and patients (n = 31) pretesting in Denmark, Poland, and the UK lead to a final list of 20 items.

CONCLUSION:

The selection, development, and refining of NV items have been described. The nature of this testing ensures an initial CAT item bank that after field testing (phase 4) and psychometric analysis is expected to provide a precise and efficient NV measurement while still being comparable to the original QLQ-C30 scale. IMPLICATIONS FOR NURSING PRACTICE Access to reliable tools that facilitate NV comprehensive assessment is an important issue for nurses caring for patients with cancer. This CAT item bank is meant to support clinical decisions when all phases of testing are completed.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Qualité de vie / Tumeurs Type d'étude: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Aspects: Patient_preference Limites: Humans Langue: En Journal: Semin Oncol Nurs Sujet du journal: ENFERMAGEM / NEOPLASIAS Année: 2022 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Qualité de vie / Tumeurs Type d'étude: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Aspects: Patient_preference Limites: Humans Langue: En Journal: Semin Oncol Nurs Sujet du journal: ENFERMAGEM / NEOPLASIAS Année: 2022 Type de document: Article